Genome Profiling, LLC
To discover novel epigenetic biomarkers based on proprietary, genome-wide methylation profiling platform to revolutionize the way to treat, diagnose, and predict chronic and life threatening disease.
Active Portfolio Company
To discover novel epigenetic biomarkers based on proprietary, genome-wide methylation profiling platform to revolutionize the way to treat, diagnose, and predict chronic and life threatening disease.
Active Portfolio Company